The British Medical Association (BMA) leaders have discussed their approach to children and young people with gender identity issues, focusing on the Cass review’s findings. This review, led by Dr. Hilary Cass and published in April, highlighted the lack of research and weak evidence on medical interventions for gender care, which led the government to ban puberty blockers for gender identity reasons. This decision, maintained by Health Secretary Wes Streeting, has been criticized by BMA council member Dr. Emma Runswick as harmful and politically motivated. While the BMA refuted claims that it would disavow the review, it acknowledged the debate on the “woefully inadequate” services for gender dysphoria and committed to further work to improve care for this population.
2 Likes
This is such an important issue! The debate around the Cass review and the ban on puberty blockers is really complex. Do you know if the BMA has a timeline for when they’ll release their stance on this? And how might this decision impact the care provided to children and young people with gender dysphoria in the near future?